Kinetics of transperitoneal tissue-type plasminogen activator absorption

被引:11
作者
Holmdahl, L
Eriksson, E
Rippe, B
Risberg, B
机构
[1] UNIV LUND HOSP,DEPT NEPHROL,S-22185 LUND,SWEDEN
[2] LUND UNIV,MALMO GEN HOSP,DEPT SURG,S-21401 MALMO,SWEDEN
关键词
D O I
10.1016/S0268-9499(05)80069-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal hypofibrinolysis has been suggested to be a central denominator in the formation of postoperative adhesions. Topical application of tissue-type plasminogen activator (t-PA) has been demonstrated to reduce adhesion formation, but the absorption of t-PA is not known. The aim of the present study was to determine the absorptive kinetics of t-PA by injecting varying doses of t-PA in intraperitoneally (i.p.) in rats. Plasma elimination was investigated in another set of experiments, where the same doses were injected intravenously (i.v.), The concentrations of t-PA in plasma were dose-dependent after both administrations, and at three and six hours the t-PA concentration in plasma was significantly higher after i.p. [64 (12.8) ng/mL (40 mu g dose)] and [297.6 (6.7) (400 mu g dose)] then after i.v. [27.9 (15.8) (40 mu g dose)] and [127.0 (35.0) (400 mu g dose)] (P<0.05). Uptake rate of t-PA from the peritoneal cavity was 2.4-6.2 mu L/min, which is compatible with peritoneal lymph flow, Plasma clearance was rapid after an i.v. injection (3.3-5.7 mL/min), and slower (0.8-1.7 mL/min) after i.p. administration, indicating a greater availability of t-PA when given i.p. To increase abdominal fibrinolytic capacity without affecting systemic fibrinolysis, a slow-release form of t-PA has to be used. The finding that i.p. administration gave rise to prolonged elevation of plasma concentration as compared to an i.v. injection may have some therapeutic implications in thrombolysis.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 31 条
[1]  
AUNE S, 1970, SCAND J GASTROENTERO, V5, P241
[2]   TURNOVER OF HUMAN-TISSUE PLASMINOGEN-ACTIVATOR (TPA) IN RABBITS [J].
BEEBE, DP ;
ARONSON, DL .
THROMBOSIS RESEARCH, 1986, 43 (06) :663-674
[3]   BINDING OF TISSUE PLASMINOGEN-ACTIVATOR TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
BEEBE, DP .
THROMBOSIS RESEARCH, 1987, 46 (02) :241-254
[4]   INVARIANTS IN EXPERIMENTAL DATA ON LINEAR KINETICS AND THE FORMULATION OF MODELS [J].
BERMAN, M ;
SCHOENFELD, R .
JOURNAL OF APPLIED PHYSICS, 1956, 27 (11) :1361-1370
[5]  
BIRKENFELD A, 1983, ANN CHIR GYNAECOL, V72, P246
[6]  
BUCKMAN RF, 1975, CLIN RES, V23, P15
[7]  
DOODY KJ, 1989, FERTIL STERIL, V51, P509
[8]   PREVENTION OF POSTOPERATIVE ADHESIONS BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN THE RABBIT [J].
DORR, PJ ;
VEMER, HM ;
BROMMER, EJP ;
WILLEMSEN, WNP ;
VELDHUIZEN, RW ;
ROLLAND, R .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1990, 37 (03) :287-291
[9]  
DUNN RC, 1990, PROG CLIN BIOL RES, V358, P113
[10]   EFFECT OF VARYING DAYS OF TISSUE PLASMINOGEN-ACTIVATOR THERAPY ON THE PREVENTION OF POSTSURGICAL ADHESIONS IN A RABBIT MODEL [J].
DUNN, RC ;
MOHLER, M .
JOURNAL OF SURGICAL RESEARCH, 1993, 54 (03) :242-245